NAYA Biosciences Inc. Com...

NASDAQ: IVF · Real-Time Price · USD
1.56
-0.19 (-10.86%)
At close: Aug 15, 2025, 3:59 PM
1.59
1.90%
After-hours: Aug 15, 2025, 07:58 PM EDT

NAYA Biosciences Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-17.4M -3.62M -1.63M -2.25M -1.6M -1.99M -1.25M -2.24M -2.55M -2.77M -2.55M -2.8M -2.77M 97.02K -2.48M -1.82M -2.45M
Depreciation & Amortization
234.46K 231.81K 230.5K 230.34K 226.96K 141.6K 20.5K 19.7K 19.09K 77.55K 19.73K -34.82K 72.45K 79.36K 46.42K 31.66K 8.65K
Stock-Based Compensation
70.66K 169.37K 106.33K 1.1M 213.84K 179.53K 265.47K 426.25K 522.24K 412.2K 505.62K 567.9K 738.7K 999.06K 521.32K 619.23K 568.59K
Other Working Capital
-278.83K 824.56K 134.76K -308.94K -148.71K 558.73K -677.45K 36.02K 141.7K 384.66K 99.92K 228.05K -189.75K -3.01M -54.07K -216.72K -393.34K
Other Non-Cash Items
14.76M 611.75K 259.02K 268.62K 610.05K 434.1K 364.32K 163.93K 251.12K 219.86K 66.47K 147.98K 71.12K 387.4K 189.81K -80.64K 860.15K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.21M 1.99M 394.01K -809.55K 285.11K 524.67K -649.17K -13.78K 609.98K 1.05M 309.55K 247.68K -186.07K -3.07M 114.11K 73.17K -719.31K
Operating Cash Flow
-3.55M -617.38K -640.81K -1.46M -260.56K -714.88K -1.25M -1.64M -1.15M -1M -1.65M -1.87M -2.08M -1.51M -1.61M -1.17M -1.74M
Capital Expenditures
-14.65K -78.87K n/a -55.13K -49.7K -75K -108.22K n/a n/a n/a -3.01K -3.29K -6.56K n/a -747.41K -6.4K -28.98K
Cash Acquisitions
n/a 472.01K n/a n/a n/a 108.29K -2.15M n/a -8.45K 8.45K n/a -1.61K -75.33K -1.45M 627.12K -880K n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 50K 25.59K n/a n/a n/a n/a n/a -426 -607 -910 199.6K -203.16K 280K -280K
Investing Cash Flow
-14.65K 393.13K n/a -5.13K -24.11K 33.29K -2.26M -261.5K -8.45K 8.58K -3.01K -4.9K -81.89K -917.84K -320.29K -606.4K -308.98K
Debt Repayment
-1.09M 494.05K 31.96K -143.55K 27.37K -141.53K 1.45M -190.15K 544K n/a n/a n/a n/a -250K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
88.00 n/a n/a 900.61K n/a 23.05K n/a -1 2.38K 800K n/a n/a n/a 3.65M n/a n/a 369.84K
Financial Cash Flow
3.66M 494.05K 169.46K 1.93M 527.37K -141.53K 4.45M -169.86K 3.26M 800K -25.2K n/a 315K 3.4M n/a n/a 369.84K
Net Cash Flow
99.01K 269.81K -471.34K 467.81K 242.7K -823.12K 943.06K -2.08M 2.1M -195.56K -1.68M -1.88M -1.85M 971.75K -1.93M -1.78M -1.67M
Free Cash Flow
-3.56M -696.25K -640.81K -1.51M -310.25K -789.88K -1.36M -1.91M -1.15M -1M -1.65M -1.88M -2.08M -1.18M -2.36M -1.18M -1.76M